Similar articles for PMID: 22447922

Year	Number of Results
2003	2
2004	3
2006	3
2008	5
2009	3
2010	5
2011	11
2012	15
2013	11
2014	7
2015	4
2016	9
2017	6
2018	5
2019	9
2020	8
2021	5
2024	0

1

Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections.

Müller BM, Brase JC, Haufe F, Weber KE, Budzies J, Petry C, Prinzler J, Kronenwett R, Dietel M, Denkert C. Müller BM, et al. J Clin Pathol. 2012 Jul;65(7):660-2. doi: 10.1136/jclinpath-2012-200716. Epub 2012 Mar 23. J Clin Pathol. 2012. PMID: 22447922 Free PMC article.

2

Efficacy of an RNA-based multigene assay with core needle biopsy samples for risk evaluation in hormone-positive early breast cancer.

Lee J, Lee EH, Park HY, Kim WW, Lee RK, Chae YS, Lee SJ, Kim JE, Kang BI, Park JY, Park JY, Jung JH. Lee J, et al. BMC Cancer. 2019 Apr 25;19(1):388. doi: 10.1186/s12885-019-5608-2. BMC Cancer. 2019. PMID: 31023265 Free PMC article.

3

Decentral gene expression analysis for ER+/Her2- breast cancer: results of a proficiency testing program for the EndoPredict assay.

Denkert C, Kronenwett R, Schlake W, Bohmann K, Penzel R, Weber KE, Höfler H, Lehmann U, Schirmacher P, Specht K, Rudas M, Kreipe HH, Schraml P, Schlake G, Bago-Horvath Z, Tiecke F, Varga Z, Moch H, Schmidt M, Prinzler J, Kerjaschki D, Sinn BV, Müller BM, Filipits M, Petry C, Dietel M. Denkert C, et al. Virchows Arch. 2012 Mar;460(3):251-9. doi: 10.1007/s00428-012-1204-4. Epub 2012 Feb 28. Virchows Arch. 2012. PMID: 22371223 Free PMC article.

4

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.

Sinn HP, Schneeweiss A, Keller M, Schlombs K, Laible M, Seitz J, Lakis S, Veltrup E, Altevogt P, Eidt S, Wirtz RM, Marmé F. Sinn HP, et al. BMC Cancer. 2017 Feb 13;17(1):124. doi: 10.1186/s12885-017-3111-1. BMC Cancer. 2017. PMID: 28193205 Free PMC article.

5

EndoPredict^® in early hormone receptor-positive, HER2-negative breast cancer.

Almstedt K, Mendoza S, Otto M, Battista MJ, Steetskamp J, Heimes AS, Krajnak S, Poplawski A, Gerhold-Ay A, Hasenburg A, Denkert C, Schmidt M. Almstedt K, et al. Breast Cancer Res Treat. 2020 Jul;182(1):137-146. doi: 10.1007/s10549-020-05688-1. Epub 2020 May 20. Breast Cancer Res Treat. 2020. PMID: 32436145 Free PMC article.

6

Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.

Peláez-García A, Yébenes L, Berjón A, Angulo A, Zamora P, Sánchez-Méndez JI, Espinosa E, Redondo A, Heredia-Soto V, Mendiola M, Feliú J, Hardisson D. Peláez-García A, et al. PLoS One. 2017 Sep 8;12(9):e0183452. doi: 10.1371/journal.pone.0183452. eCollection 2017. PLoS One. 2017. PMID: 28886093 Free PMC article.

7

Concordance of the molecular subtype classification between core needle biopsy and surgical specimen in primary breast cancer.

Pölcher M, Braun M, Tischitz M, Hamann M, Szeterlak N, Kriegmair A, Brambs C, Becker C, Stoetzer O. Pölcher M, et al. Arch Gynecol Obstet. 2021 Sep;304(3):783-790. doi: 10.1007/s00404-021-05996-x. Epub 2021 Feb 14. Arch Gynecol Obstet. 2021. PMID: 33585986

8

Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer.

Munch-Petersen HD, Rasmussen BB, Balslev E. Munch-Petersen HD, et al. APMIS. 2014 Sep;122(9):750-4. doi: 10.1111/apm.12213. Epub 2013 Dec 21. APMIS. 2014. PMID: 24372587

9

The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer.

Soran A, Bhargava R, Johnson R, Ahrendt G, Bonaventura M, Diego E, McAuliffe PF, Serrano M, Menekse E, Sezgin E, McGuire KP. Soran A, et al. Breast Dis. 2016 Jul 28;36(2-3):65-71. doi: 10.3233/BD-150199. Breast Dis. 2016. PMID: 27662272

10

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.

Vohra P, Buelow B, Chen YY, Serrano M, Vohra MS, Berry A, Ljung BM. Vohra P, et al. Cancer Cytopathol. 2016 Nov;124(11):828-835. doi: 10.1002/cncy.21745. Epub 2016 Jun 17. Cancer Cytopathol. 2016. PMID: 27315045 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year